These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

161 related items for PubMed ID: 8740360

  • 1. X-ray structure of a hydroxamate inhibitor complex of stromelysin catalytic domain and its comparison with members of the zinc metalloproteinase superfamily.
    Dhanaraj V, Ye QZ, Johnson LL, Hupe DJ, Ortwine DF, Dunbar JB, Rubin JR, Pavlovsky A, Humblet C, Blundell TL.
    Structure; 1996 Apr 15; 4(4):375-86. PubMed ID: 8740360
    [Abstract] [Full Text] [Related]

  • 2. Designing inhibitors of the metalloproteinase superfamily: comparative analysis of representative structures.
    Dhanaraj V, Ye QZ, Johnson LL, Hupe DJ, Ortwine DF, Dunbar JB, Rubin JR, Pavlovsky A, Humblet C, Blundell TL.
    Drug Des Discov; 1996 Apr 15; 13(3-4):3-14. PubMed ID: 8874040
    [Abstract] [Full Text] [Related]

  • 3. Crystal structure of the stromelysin catalytic domain at 2.0 A resolution: inhibitor-induced conformational changes.
    Chen L, Rydel TJ, Gu F, Dunaway CM, Pikul S, Dunham KM, Barnett BL.
    J Mol Biol; 1999 Oct 29; 293(3):545-57. PubMed ID: 10543949
    [Abstract] [Full Text] [Related]

  • 4. Solution structure of the catalytic domain of human collagenase-3 (MMP-13) complexed to a potent non-peptidic sulfonamide inhibitor: binding comparison with stromelysin-1 and collagenase-1.
    Zhang X, Gonnella NC, Koehn J, Pathak N, Ganu V, Melton R, Parker D, Hu SI, Nam KY.
    J Mol Biol; 2000 Aug 11; 301(2):513-24. PubMed ID: 10926524
    [Abstract] [Full Text] [Related]

  • 5. X-ray structures of human neutrophil collagenase complexed with peptide hydroxamate and peptide thiol inhibitors. Implications for substrate binding and rational drug design.
    Grams F, Reinemer P, Powers JC, Kleine T, Pieper M, Tschesche H, Huber R, Bode W.
    Eur J Biochem; 1995 Mar 15; 228(3):830-41. PubMed ID: 7737183
    [Abstract] [Full Text] [Related]

  • 6. Crystal structures of the catalytic domain of human stromelysin-1 (MMP-3) and collagenase-3 (MMP-13) with a hydroxamic acid inhibitor SM-25453.
    Kohno T, Hochigai H, Yamashita E, Tsukihara T, Kanaoka M.
    Biochem Biophys Res Commun; 2006 May 26; 344(1):315-22. PubMed ID: 16603129
    [Abstract] [Full Text] [Related]

  • 7. Solution structure of the catalytic domain of human stromelysin-1 complexed to a potent, nonpeptidic inhibitor.
    Li YC, Zhang X, Melton R, Ganu V, Gonnella NC.
    Biochemistry; 1998 Oct 06; 37(40):14048-56. PubMed ID: 9760240
    [Abstract] [Full Text] [Related]

  • 8. Solution structure of the catalytic domain of human stromelysin complexed with a hydrophobic inhibitor.
    Van Doren SR, Kurochkin AV, Hu W, Ye QZ, Johnson LL, Hupe DJ, Zuiderweg ER.
    Protein Sci; 1995 Dec 06; 4(12):2487-98. PubMed ID: 8580839
    [Abstract] [Full Text] [Related]

  • 9. X-ray structure of a novel matrix metalloproteinase inhibitor complexed to stromelysin.
    Dunten P, Kammlott U, Crowther R, Levin W, Foley LH, Wang P, Palermo R.
    Protein Sci; 2001 May 06; 10(5):923-6. PubMed ID: 11316871
    [Abstract] [Full Text] [Related]

  • 10. Crystal structure of human macrophage elastase (MMP-12) in complex with a hydroxamic acid inhibitor.
    Nar H, Werle K, Bauer MM, Dollinger H, Jung B.
    J Mol Biol; 2001 Sep 28; 312(4):743-51. PubMed ID: 11575929
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Structural characterizations of nonpeptidic thiadiazole inhibitors of matrix metalloproteinases reveal the basis for stromelysin selectivity.
    Finzel BC, Baldwin ET, Bryant GL, Hess GF, Wilks JW, Trepod CM, Mott JE, Marshall VP, Petzold GL, Poorman RA, O'Sullivan TJ, Schostarez HJ, Mitchell MA.
    Protein Sci; 1998 Oct 28; 7(10):2118-26. PubMed ID: 9792098
    [Abstract] [Full Text] [Related]

  • 13. The NMR structure of the inhibited catalytic domain of human stromelysin-1.
    Gooley PR, O'Connell JF, Marcy AI, Cuca GC, Salowe SP, Bush BL, Hermes JD, Esser CK, Hagmann WK, Springer JP.
    Nat Struct Biol; 1994 Feb 28; 1(2):111-8. PubMed ID: 7656014
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. X-ray structure of human stromelysin catalytic domain complexed with nonpeptide inhibitors: implications for inhibitor selectivity.
    Pavlovsky AG, Williams MG, Ye QZ, Ortwine DF, Purchase CF, White AD, Dhanaraj V, Roth BD, Johnson LL, Hupe D, Humblet C, Blundell TL.
    Protein Sci; 1999 Jul 28; 8(7):1455-62. PubMed ID: 10422833
    [Abstract] [Full Text] [Related]

  • 18. Structure of full-length porcine synovial collagenase reveals a C-terminal domain containing a calcium-linked, four-bladed beta-propeller.
    Li J, Brick P, O'Hare MC, Skarzynski T, Lloyd LF, Curry VA, Clark IM, Bigg HF, Hazleman BL, Cawston TE.
    Structure; 1995 Jun 15; 3(6):541-9. PubMed ID: 8590015
    [Abstract] [Full Text] [Related]

  • 19. Solution structures of stromelysin complexed to thiadiazole inhibitors.
    Stockman BJ, Waldon DJ, Gates JA, Scahill TA, Kloosterman DA, Mizsak SA, Jacobsen EJ, Belonga KL, Mitchell MA, Mao B, Petke JD, Goodman L, Powers EA, Ledbetter SR, Kaytes PS, Vogeli G, Marshall VP, Petzold GL, Poorman RA.
    Protein Sci; 1998 Nov 15; 7(11):2281-6. PubMed ID: 9827994
    [Abstract] [Full Text] [Related]

  • 20. Structure of the catalytic domain of human fibroblast collagenase complexed with an inhibitor.
    Borkakoti N, Winkler FK, Williams DH, D'Arcy A, Broadhurst MJ, Brown PA, Johnson WH, Murray EJ.
    Nat Struct Biol; 1994 Feb 15; 1(2):106-10. PubMed ID: 7656013
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.